ConductScience.org, home

Paper32017286

Tumor immune microenvironment in head and neck cancers.

Chen SMY and 5 others. Mol Carcinog, 2020. Cited by 153 papers, by iCite.

Cite this record

ConductScience Library. Tumor immune microenvironment in head and neck cancers. Papers, record 32017286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32017286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor immune microenvironment in head and neck cancers.
PubMed
Journal
Mol Carcinog
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
153
iCite
Relative citation ratio, by iCite
7.01
iCite
Revised in PubMed
2022-02-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen SMYSamantha M Y
2Krinsky ALAlexandra L
3Woolaver RARachel A
4Wang XXiaoguang
5Chen ZZhangguo
6Wang JHJing Hhttps://orcid.org/0000-0003-4343-2527

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Head and Neck NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
Animals
Cell Transformation, Neoplastic
Humans
Immunotherapy
Squamous Cell Carcinoma of Head and Neck

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
F31 DE027854NIDCR NIH HHSUnited StatesF31DE027854PubMed and NIHNIH RePORTER
T32 AI007405NIAID NIH HHSUnited StatesT32AI007405PubMed and NIHNIH RePORTER
T32 CA174648NCI NIH HHSUnited StatesT32CA174648PubMedNIH RePORTER
R01 DE028420NIDCR NIH HHSUnited StatesR01DE028420PubMed and NIHNIH RePORTER
R01 DE027329NIDCR NIH HHSUnited StatesR01DE027329PubMed and NIHNIH RePORTER

Download CSV of grants

References130

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129147608The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.Oncoimmunology2017https://conductscience.org/library/papers/29147608PubMed
227956380Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.Cancer Immunol Res2017https://conductscience.org/library/papers/27956380PubMed
329563330CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.JCI Insight2018https://conductscience.org/library/papers/29563330PubMed
428811959T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.Oncoimmunology2017https://conductscience.org/library/papers/28811959PubMed
519183242Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck.J Cell Mol Med2010https://conductscience.org/library/papers/19183242PubMed
625428507Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.Nature2014https://conductscience.org/library/papers/25428507PubMed
725837513Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.Science2015https://conductscience.org/library/papers/25837513PubMed
822313874Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.Semin Cancer Biol2012https://conductscience.org/library/papers/22313874PubMed
927718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
1026168215Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.J Clin Invest2015https://conductscience.org/library/papers/26168215PubMed
1126089604Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.Mediators Inflamm2015https://conductscience.org/library/papers/26089604PubMed
1227265504CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Cancer Cell2016https://conductscience.org/library/papers/27265504PubMed
1328115575The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment.J Exp Med2017https://conductscience.org/library/papers/28115575PubMed
1428650338IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.J Clin Invest2017https://conductscience.org/library/papers/28650338PubMed
1528491874Innate-Adaptive Immune Crosstalk 2016.J Immunol Res2017https://conductscience.org/library/papers/28491874PubMed
1631308358Clinical update on head and neck cancer: molecular biology and ongoing challenges.Cell Death Dis2019https://conductscience.org/library/papers/31308358PubMed
1727339708The role of myeloid cells in cancer therapies.Nat Rev Cancer2016https://conductscience.org/library/papers/27339708PubMed
1824935016Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.Nat Rev Clin Oncol2014https://conductscience.org/library/papers/24935016PubMed
1916034368Cancer/testis antigens, gametogenesis and cancer.Nat Rev Cancer2005https://conductscience.org/library/papers/16034368PubMed
2029254756Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.Semin Immunol2018https://conductscience.org/library/papers/29254756PubMed

See all 130 referencesDownload CSV of references

Cited by116

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.

PMIDTitleJournalYearIn PapersSource
42618717Tumor-derived PTX3 drives an immunosuppressive myeloid landscape and inhibits CD8 T cell-mediated anti-tumor immunity via PI3K-dependent signaling.Oncogene2026https://conductscience.org/library/papers/42618717PubMed
42614551Single-cell RNA sequencing reveals hypoxia-associated stress response signatures in the immune and stromal microenvironment of laryngeal squamous cell carcinoma.Front Immunol2026https://conductscience.org/library/papers/42614551PubMed
42414478Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas.NPJ Precis Oncol2026https://conductscience.org/library/papers/42414478PubMed
42292754Prognostic Impact and Clinicopathological Significance of TIM-3 and LAG-3 Expressions in Laryngeal Squamous Cell Carcinoma.Laryngoscope Investig Otolaryngol2026https://conductscience.org/library/papers/42292754PubMed
42265804Multifactorial effects of LGALS1 blockade sensitize tumors to immune checkpoint inhibitor.Exp Hematol Oncol2026https://conductscience.org/library/papers/42265804PubMed
42221217
Development of a Prognostic Nomogram Model and Establishment of a Risk Stratification System Based on the Naples Prognostic Score for Patients with Oropharyngeal Squamous Cell Carcinoma Who Have Undergone Radical Surgery.
J Inflamm Res2026https://conductscience.org/library/papers/42221217PubMed
42185849Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications.Cancer Cell Int2026https://conductscience.org/library/papers/42185849PubMed
41993185Red-complex bacteria: immunological background leading to the development of head and neck cancers.Front Immunol2026https://conductscience.org/library/papers/41993185PubMed
41929629Multi-omics analysis identifies CLDN10 as a B-cell-associated prognostic biomarker in HPV-negative head and neck squamous cell carcinoma.Front Cell Dev Biol2026https://conductscience.org/library/papers/41929629PubMed
41879001LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma.Cancer Med2026https://conductscience.org/library/papers/41879001PubMed
41713051Hydrogels in head and neck cancer: Innovations and translational advances in research and therapy.Biomaterials2026https://conductscience.org/library/papers/41713051PubMed
41710363Next Generation Calcium Nanomaterials: Disrupting Tumor Ca2⁺ Homeostasis for Enhanced Cancer Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/41710363PubMed
41627880Driving progress in recurrent and metastatic head and neck cancer: the NRG Oncology perspective.J Natl Cancer Inst2026https://conductscience.org/library/papers/41627880PubMed
41624538NIR-II biomimetic nanoplatform optogenetic CD274 editing of HNSCC immunogenicity for enhanced photoimmunotherapy.Mater Today Bio2026https://conductscience.org/library/papers/41624538PubMed
41614901Role of the Super-Enhancer Component Bromodomain Protein 4 in the Radiation Response of Human Head and Neck Squamous Cell Carcinoma Cells.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41614901PubMed
41588455Analysis of the efficacy of camrelizumab/cetuximab neoadjuvant therapy in patients with loco-regionally advanced laryngeal and hypopharyngeal cancer and the prognostic value of NLR/SII.World J Surg Oncol2026https://conductscience.org/library/papers/41588455PubMed
41585201Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.J Dent Sci2026https://conductscience.org/library/papers/41585201PubMed
41225107Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.Adv Exp Med Biol2026https://conductscience.org/library/papers/41225107PubMed
40910245Nano-Engineered Cetuximab-Copper Complexes for Targeted Drug Delivery in Head and Neck Cancer.Curr Drug Deliv2026https://conductscience.org/library/papers/40910245PubMed
40864763Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40864763PubMed

See all 116 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ARG1383PubTator's text mininghttps://conductscience.org/library/genes/383NCBI Gene
CD24451744PubTator's text mininghttps://conductscience.org/library/genes/51744NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD70970PubTator's text mininghttps://conductscience.org/library/genes/970NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCR23579PubTator's text mininghttps://conductscience.org/library/genes/3579NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IDO13620PubTator's text mininghttps://conductscience.org/library/genes/3620NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32017286

GET https://conductscience.org/api/papers/v1/32017286/references?page=2